<SEC-DOCUMENT>0001193125-21-185455.txt : 20210608
<SEC-HEADER>0001193125-21-185455.hdr.sgml : 20210608
<ACCEPTANCE-DATETIME>20210608163520
ACCESSION NUMBER:		0001193125-21-185455
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210601
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210608
DATE AS OF CHANGE:		20210608

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VERACYTE, INC.
		CENTRAL INDEX KEY:			0001384101
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				205455398
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36156
		FILM NUMBER:		211002546

	BUSINESS ADDRESS:	
		STREET 1:		6000 SHORELINE COURT, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 243-6300

	MAIL ADDRESS:	
		STREET 1:		6000 SHORELINE COURT, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CALDEROME INC
		DATE OF NAME CHANGE:	20061219
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>d188784d8ka.htm
<DESCRIPTION>8-K/A
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vcyt="http://www.veracyte.com/20210601" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:srt-types="http://fasb.org/srt/2020-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K/A</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2021-06-01_to_2021-06-01" name="dei:AmendmentFlag" contextRef="duration_2021-06-01_to_2021-06-01">true</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2021-06-01_to_2021-06-01" name="dei:EntityCentralIndexKey" contextRef="duration_2021-06-01_to_2021-06-01">0001384101</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="vcyt-20210601.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-06-01_to_2021-06-01"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001384101</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-06-01</xbrli:startDate> <xbrli:endDate>2021-06-01</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-06-01_to_2021-06-01">8-K/A</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-06-01_to_2021-06-01" format="ixt:datemonthdayyearen">June 1, 2021</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2021-06-01_to_2021-06-01" name="dei:EntityRegistrantName">VERACYTE, INC.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2021-06-01_to_2021-06-01" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2021-06-01_to_2021-06-01" name="dei:EntityFileNumber">001-36156</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2021-06-01_to_2021-06-01" name="dei:EntityTaxIdentificationNumber">20-5455398</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr> </table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2021-06-01_to_2021-06-01" name="dei:EntityAddressAddressLine1">6000 Shoreline Court</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2021-06-01_to_2021-06-01">Suite&#160;300</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2021-06-01_to_2021-06-01" name="dei:EntityAddressCityOrTown">South San Francisco</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2021-06-01_to_2021-06-01" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2021-06-01_to_2021-06-01" name="dei:EntityAddressPostalZipCode">94080</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="duration_2021-06-01_to_2021-06-01" name="dei:CityAreaCode">650</ix:nonNumeric>) <span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2021-06-01_to_2021-06-01" name="dei:LocalPhoneNumber">243-6300</ix:nonNumeric></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-06-01_to_2021-06-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-06-01_to_2021-06-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-06-01_to_2021-06-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2021-06-01_to_2021-06-01" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr> </table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:35%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:31%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-06-01_to_2021-06-01">Common Stock, par value, $0.001 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-06-01_to_2021-06-01">VCYT</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-06-01_to_2021-06-01" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr> </table> <p style="margin-top:10pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934.</p> <p style="margin-top:10pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-06-01_to_2021-06-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Explanatory Note</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="dei:AmendmentDescription" contextRef="duration_2021-06-01_to_2021-06-01">This Amendment No.&#160;1 on Form <span style="white-space:nowrap">8-K/A</span> is an amendment to the Current Report on Form <span style="white-space:nowrap">8-K</span> (the &#8220;Form <span style="white-space:nowrap">8-K&#8221;)</span> of Veracyte, Inc., a Delaware corporation (&#8220;Veracyte&#8221;), filed with the Securities and Exchange Commission on June&#160;1, 2021, for the sole purpose of removing the check mark in the box relating to written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425), which was inadvertently checked in the Form <span style="white-space:nowrap">8-K.</span> All other information in the Form <span style="white-space:nowrap">8-K</span> is unchanged.</ix:nonNumeric></p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;1.01.</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;1, 2021, Veracyte announced that it had negotiated a Securities Purchase and Contribution Agreement (the &#8220;SPA&#8221;) for the acquisition of HalioDx SAS, a French soci&#233;t&#233; par actions simplifi&#233;e (&#8220;HalioDx&#8221;), for a purchase price of &#8364;260&#160;million in total consideration to HalioDx securityholders, consisting of approximately &#8364;147&#160;million in cash and up to approximately &#8364;113&#160;million in shares of Veracyte common stock, subject to customary purchase price adjustments (the &#8220;Acquisition&#8221;). The number of Veracyte shares to be issued will be based on a <span style="white-space:nowrap">10-day</span> volume-weighted trading average of Veracyte shares prior to the closing date of the Acquisition (the &#8220;Closing Date&#8221;), and the SPA requires Veracyte to register the resale of such share consideration, if any, within two business days of the Closing Date. However, the SPA provides Veracyte with the option, at its sole discretion, to substitute cash in lieu of shares in any amount up to the entire acquisition consideration, without changing the total consideration paid at closing. The SPA provides for approximately 10% of the total consideration to be paid into escrow to secure certain indemnification obligations of the HalioDx securityholders. In addition, the SPA provides for approximately 20% of the consideration to be paid to certain founders of HalioDx to be subject to a holdback provision, contingent upon their continued employment with Veracyte over the two years following the closing.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the negotiation of the SPA, on June&#160;1, 2021, Veracyte entered into a Memorandum of Understanding (&#8220;MOU&#8221;) with the securityholders of HalioDx (the &#8220;Sellers&#8221;) relating to the future execution of the SPA. As set forth in the MOU, Veracyte has an exclusivity period extending from June&#160;1, 2021 to the earlier of (1)&#160;the execution of the SPA and (2)&#160;the date that is six months following the execution of the MOU. During such exclusivity period, the Sellers shall not initiate, solicit, encourage, respond to or facilitate any inquiry, proposal or offer by any third party with respect to any acquisition of all or part of the share capital of any Group Companies (as defined in the SPA) and/or all or part of their assets, or to proceed with the merger, <span style="white-space:nowrap">spin-off,</span> contribution, business combination or any similar transaction involving the Group Companies. In addition, during such exclusivity period, the Sellers cannot furnish any information or afford access to the business, financial position, properties, assets or the books and records of the Group Companies to any person or entity in connection with any competing proposal to the MOU. Pursuant to the MOU, the Sellers agreed to cause the Group Companies to operate in the ordinary course of business and to refrain from taking certain actions until the earlier of the execution date of the SPA or the expiration of the MOU.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the execution of the MOU, the Sellers will inform and consult with the works council of HalioDx regarding the acquisition. Upon the completion of such consultation process and the Sellers&#8217; agreement to enter into the SPA, the MOU irrevocably commits Veracyte to execute and deliver the SPA within ten business days.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the execution of the SPA, Veracyte&#8217;s and the Sellers&#8217; obligations to complete the Acquisition will be subject to customary closing conditions, including French foreign investment authorization; provided, that in the event the SPA is executed but such foreign investment authorization is not obtained, Veracyte has agreed to pay a <span style="white-space:nowrap">break-up</span> fee of &#8364;1&#160;million to the Sellers. The form of SPA attached to the MOU also includes certain customary representations, warranties, covenants and indemnities of the parties.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing descriptions of the SPA and MOU are included to provide you with information regarding their terms, do not purport to be complete descriptions of the terms of such agreements and are qualified in their entirety by reference to the full text of the SPA and MOU, copies of which will be filed with Veracyte&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the fiscal quarter ending June&#160;30, 2021.</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Press Release </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;1, 2021, Veracyte issued a press release announcing the proposed Acquisition (the &#8220;Press Release&#8221;). The Press Release is being filed as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span></p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Forward-Looking Statements</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K,</span> including the Press Release, contains &#8220;forward-looking&#8221; statements within the meaning of Section&#160;27A of the Securities Act and Section&#160;21E of the Exchange Act which involve risks and uncertainties. These forward-looking statements include, but are not limited to, that the SPA may not be entered into and the transaction may not be pursued following works council review in France; the possibility that the closing conditions to the proposed transaction may not be satisfied or waived, including that a governmental entity may not grant a required regulatory approval; delay in closing the transaction or the possibility of <span style="white-space:nowrap">non-consummation</span> of the transaction; the risk of stockholder litigation in connection with contemplated transaction; the retention of HalioDx employees and Veracyte&#8217;s ability to successfully integrate the HalioDx business; and risks inherent in the achievement of anticipated synergies and the timing thereof. You can identify these statements by the use of terminology such as &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;will&#8221;, &#8220;should,&#8221; &#8220;could&#8221;, &#8220;estimate&#8221;, &#8220;anticipate&#8221; or similar forward-looking terms. You should not rely on these forward-looking statements as they involve risks and uncertainties that may cause actual results to vary materially from the forward-looking statements. For more information regarding the risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements, as well as risks relating to Veracyte&#8217;s business in general, Veracyte refers you to the &#8220;Risk Factors&#8221; section of Veracyte&#8217;s Securities and Exchange Commission (&#8220;SEC&#8221;)&#160;filings, including Veracyte&#8217;s most recent Form <span style="white-space:nowrap">10-K</span> and <span style="white-space:nowrap">10-Q,</span> which are available on the Investor Relations page of Veracyte&#8217;s website at https://investor.veracyte.com/ and on the SEC website at www.sec.gov. The risks and uncertainties may be amplified by the <span style="white-space:nowrap">COVID-19</span> pandemic, which has caused significant economic uncertainty. The extent to which the <span style="white-space:nowrap">COVID-19</span> pandemic impacts Veracyte&#8217;s and HalioDx&#8217;s businesses, operations, and financial results, including the duration and magnitude of such effects, will depend on numerous factors, which are unpredictable, including, but not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. Veracyte undertakes no obligation to update any of these forward-looking statements for any reason after the date of this communication or to conform these statements to actual results or revised expectations, except as required by law.</p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit Title or Description</span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d188784dex991.htm">Press Release issued by Veracyte, dated June&#160;1, 2021. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr></table></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: June 8, 2021</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">
<tr>
<td style="width:12%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:87%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">VERACYTE,&#160;INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James H. Erlinger</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">James H. Erlinger</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="font-style:italic">Executive Vice President and General Counsel</span></td></tr></table></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d188784dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g16438g0601063358782.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For Immediate Release </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Veracyte to Acquire HalioDx, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Positioning for Global Cancer Diagnostics Growth </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Fueling growth by enabling IVD test development and manufacturing, deepening scientific capabilities </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>and expanding cancer diagnostics scope to 8 of the 10 top cancers in the U.S. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Investor conference call and webcast today at 8:00 a.m. ET </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOUTH SAN FRANCISCO, Calif., June&nbsp;1, 2021 &#151; <U>Veracyte, Inc</U>. (Nasdaq: VCYT) today announced it has reached the terms of an agreement to acquire
HalioDx in a transaction to further accelerate growth and strengthen Veracyte&#146;s global leadership in cancer diagnostics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The acquisition of
HalioDx will further enable our long-term growth by providing key strategic capabilities to help us to execute on our powerful vision of improving outcomes for patients all over the world at every step of their journey,&#148; said Bonnie Anderson,
Veracyte&#146;s executive chairwoman. &#147;Our prior strategic acquisitions brought exclusive global access to a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> diagnostic platform and a significantly
expanded cancer testing menu. We believe HalioDx will help fuel our global growth by accelerating IVD test development and manufacturing operations in Europe and by expanding our scientific expertise into the emerging immuno-oncology field.
Additionally, their commercial-stage colon cancer immune response test will broaden our testing menu to 8 of the top 10 cancers.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HalioDx is an
immuno-oncology diagnostics company providing oncologists and drug development organizations with <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class</FONT></FONT> diagnostic products and services to guide cancer care
and contribute to precision medicine. The company provides a unique range of immune assessment solutions, including its flagship Immunoscore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> assay for assessing the immune contexture of a
tumor as a key determinant of patients&#146; outcomes and response to cancer treatments. HalioDx has developed a unique biopharma partnering ecosystem for the identification of clinically relevant biomarker signatures, the demonstration of their
utility in clinical trials and the development and commercialization of resulting IVD and companion diagnostic tests. The company operates CLIA-certified laboratories in the United States and France, as well as a manufacturing facility in France
that develops, manufactures, and distributes in vitro diagnostic clinical products. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Strategic Benefits for Global Growth </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Enables Veracyte to develop and manufacture test kits for the nCounter diagnostic platform</I>. The company
plans to transition manufacturing of the kits, currently produced by NanoString, to HalioDx&#146;s manufacturing facility in Marseille, France. This would further accelerate the expansion of test menu on the nCounter platform in Europe and other
strategic global markets. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Deepens Veracyte&#146;s scientific capabilities</I>. HalioDx&#146;s unique Immunogram multimodal analysis
platform offers potential pipeline development opportunities in a range of clinical indications and can serve as a platform to grow Veracyte&#146;s biopharma partnering business. HalioDx&#146;s deep expertise in immuno-oncology is complementary with
Veracyte&#146;s expertise in cancer genomics and large biorepository of genomic content built from whole transcriptome data. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expands Veracyte&#146;s cancer diagnostics scope to 8 of the 10 top cancers by U.S. incidence</I>. The
addition of HalioDx&#146;s Immunoscore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> test to guide treatment decisions in colorectal cancer will further expand Veracyte&#146;s menu of high-value advanced diagnostic tests that address
unmet needs at multiple points in the patient care continuum. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marc Stapley, Veracyte&#146;s chief executive officer, said, &#147;Adding HalioDx to Veracyte is a strategic
investment that we believe will position the company to unlock its growth potential. With this acquisition, we will have the parts needed to expand our business globally. Veracyte plays an increasingly vital role in advancing patient outcomes and
care, and I&#146;m excited to bring my experience building and leading complex global organizations to the company. I look forward to partnering with Bonnie, who will oversee completion of this acquisition and lead the strategic integration, and to
welcoming the HalioDx team to Veracyte so we can work together to improve care for patients all over the world.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Veracyte is a leading global
diagnostics company with strong expertise in genomic testing through both centralized and distributed tests,&#148; said Vincent Fert, HalioDx&#146;s chairman and chief executive officer. &#147;We are aligned with their mission to improve care for
patients and believe our capabilities and expertise in immuno-oncology and diagnostic development and manufacturing are highly complementary to their business and strategic vision. The transaction gives us the opportunity to significantly accelerate
the scale and scope of our offerings and continue investing in our innovative Immunogram multimodal analysis platform, which is proven in its ability to help biopharma partners understand and predict patient response to immunotherapy.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transaction Terms and Other Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon completion
of the required works council consultations, Veracyte expects that the shareholders of HalioDx will enter into a definitive purchase agreement with Veracyte for the purchase and sale of HalioDx. Upon the closing of the transaction, HalioDx will
become a subsidiary of&nbsp;Veracyte. At closing,&nbsp;Veracyte&nbsp;will pay approximately&nbsp;&#128;260 million&nbsp;in total consideration to HalioDx security holders, consisting of approximately&nbsp;&#128;147 million&nbsp;in cash and up to
approximately&nbsp;&#128;113 million&nbsp;in stock, subject to customary purchase price adjustments. The number of&nbsp;Veracyte&nbsp;shares issued in the transaction will be based on a <FONT STYLE="white-space:nowrap">10-day</FONT> volume-weighted
trading average of Veracyte shares prior to the closing date. However, without changing the total consideration paid at closing,&nbsp;Veracyte&nbsp;has the option, at its sole discretion, to substitute cash in lieu of shares in any amount up to the
entire acquisition consideration. The transaction, which has been unanimously approved by Veracyte&#146;s board of directors and is fully supported by the HalioDx board of directors, is expected to close in the third fiscal quarter of 2021, subject
to the satisfaction of customary closing conditions, including foreign investment approval in France. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Veracyte&nbsp;expects the acquisition of HalioDx to
be accretive to its revenue growth in 2021 and to expand the near-term addressable markets for Veracyte&#146;s current and pipeline tests. Veracyte also expects the transaction to be strategically accretive to its gross margins once it transitions
manufacturing of test kits to HalioDx for use on the nCounter Analysis System. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HalioDx&#146;s operations and laboratories will remain in&nbsp;Marseille,
France and Richmond, Virginia. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advisors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman
Sachs&nbsp;&amp; Co. LLC&nbsp;is serving as financial advisor to&nbsp;Veracyte, and&nbsp;Fenwick&nbsp;&amp; West LLP and Latham&nbsp;&amp; Watkins&nbsp;LLP are serving as Veracyte&#146;s legal advisors in the United States and France, respectively.
Shearman&nbsp;&amp; Sterling&nbsp;LLP is serving as legal advisor to HalioDx. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conference Call and Webcast Details </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Veracyte will host a conference call and webcast on Tuesday, June&nbsp;1, at 8:00 a.m. Eastern Time to discuss the transaction. The conference call will be
streamed live via webcast from the company&#146;s website at the following link: <U>https://edge.media-server.com/mmc/p/7nbdhd3a</U>. The webcast should be accessed 10 minutes prior to the conference call start time. A replay of the webcast will be
available for one year following the conclusion of the live broadcast and will be accessible on the company&#146;s website at https://investor.veracyte.com/events-presentations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conference call can be accessed as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="95%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">U.S./Canada participant <FONT STYLE="white-space:nowrap">dial-in</FONT> number (toll-free):</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(855) <FONT STYLE="white-space:nowrap">541-0980</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">International participant <FONT STYLE="white-space:nowrap">dial-in</FONT> number:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(970) <FONT STYLE="white-space:nowrap">315-0440</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Conference I.D.:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4412708</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Veracyte </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Veracyte (Nasdaq: VCYT) is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and
treatment decisions throughout the patient journey in cancer and other diseases. The company&#146;s growing menu of genomic tests leverages advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures
and quicken time to appropriate treatment. The company&#146;s tests in lung cancer, prostate cancer, breast cancer, thyroid cancer, bladder cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping and renal
cancer tests are in development. With Veracyte&#146;s exclusive global license to a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> diagnostics instrument platform, the company is positioned to deliver
its tests to patients worldwide. Veracyte is based in South San Francisco, California. For more information, please visit <U>www.veracyte.com</U> and follow the company on Twitter (@veracyte). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Note Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements, including, but not limited to, our statements related to our plans, objectives, expectations (financial
and otherwise) or intentions with respect to the anticipated acquisition of HalioDx; statements regarding the expected timing for completion of the transaction; statements related to the expected benefits of the proposed transaction, including but
not limited to, test menu expansion, future revenues, revenue growth and gross margin accretion, HalioDx&#146;s Immunoscore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> technology&#146;s value in both clinical care, including in
colorectal cancer diagnostics, and biopharma collaborations, and HalioDx&#146;s manufacturing capabilities and potential synergies.</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking
statements can be identified by words such as: &#147;appears,&#148; &#147;anticipate,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;expect,&#148; &#147;believe,&#148; &#147;should,&#148; &#147;may,&#148; &#147;will,&#148; &#147;positioned,&#148;
&#147;designed&#148; and similar references to future periods. Actual results may differ materially from those projected or suggested in any forward-looking statements. These statements involve risks and uncertainties, which could cause actual
results to differ materially from our predictions, and include, but are not limited to, that definitive agreements may not be entered into and the transaction may not be pursued following works council consultation in France; the possibility that
the closing conditions to the proposed transaction may not be satisfied or waived, including a governmental entity may not grant a required regulatory approval; delay in closing the transaction or the possibility of
<FONT STYLE="white-space:nowrap">non-consummation</FONT> of the transaction; the risk of stockholder litigation in connection with contemplated transaction; the retention of HalioDx employees and Veracyte&#146;s ability to successfully integrate the
HalioDx business; and risks inherent in the achievement of anticipated synergies and the timing thereof. Additional factors that may impact these forward-looking statements can be found in Item 1A &#150;&#147;Risk Factors&#148; in our Annual Report
on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed with the SEC on February&nbsp;22, 2021 and in our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> filed with the SEC on May&nbsp;10, 2021. A copy of these documents can
be found at the Investors section of our website at <U>www.veracyte.com</U>. These forward-looking statements speak only as of the date hereof and Veracyte specifically disclaims any obligation to update these forward-looking statements or reasons
why actual results might differ, whether as a result of new information, future events or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Veracyte, the Veracyte logo, Decipher, Decipher
GRID, Afirma, Percepta, Envisia, Prosigna, Lymphmark, &#147;Know by Design&#148; and &#147;More about You&#148; are registered trademarks of Veracyte, Inc. and its affiliates in the U.S. and selected countries.&nbsp;nCounter is the registered
trademark of NanoString Technologies, Inc. in the U.S. and selected countries and used by Veracyte under license.&nbsp;Immunoscore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> is the registered trademark of Inserm in the U.S. and
selected countries and is used by HalioDx under license. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"># # # </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor and Media Contact: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tracy Morris </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President of Corporate Communications </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&amp; Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Veracyte </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>tracy.morris@veracyte.com </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">650-380-4413</FONT></FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>vcyt-20210601.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 67.3 -->
<!-- Creation date: 6/8/2021 3:39:24 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:vcyt="http://www.veracyte.com/20210601"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:us-types="http://fasb.org/us-types/2020-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.veracyte.com/20210601"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vcyt-20210601_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vcyt-20210601_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>vcyt-20210601_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 67.3 -->
<!-- Creation date: 6/8/2021 3:39:24 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Three</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Three</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:type="locator" xlink:label="dei_AmendmentDescription" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Description</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Description</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>vcyt-20210601_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 67.3 -->
<!-- Creation date: 6/8/2021 3:39:24 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="vcyt-20210601.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine3" order="26.021" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="32.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:type="locator" xlink:label="dei_AmendmentDescription" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentDescription" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g16438g0601063358782.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g16438g0601063358782.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !5 '4# 2(  A$! Q$!_\0
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M)(W3=J%PPW*1D%S@_2LZROU\'O/I^J1S1Z>96DM;U8V>/:QSL<J#M(]^#ZT
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d188784d8ka_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vcyt-20210601.xsd" xlink:type="simple"/>
    <context id="duration_2021-06-01_to_2021-06-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001384101</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="duration_2021-06-01_to_2021-06-01"
      id="Hidden_dei_AmendmentFlag_duration_2021-06-01_to_2021-06-01">true</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-06-01_to_2021-06-01"
      id="Hidden_dei_EntityCentralIndexKey_duration_2021-06-01_to_2021-06-01">0001384101</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2021-06-01_to_2021-06-01">8-K/A</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-06-01_to_2021-06-01">2021-06-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2021-06-01_to_2021-06-01">VERACYTE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-06-01_to_2021-06-01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2021-06-01_to_2021-06-01">001-36156</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-06-01_to_2021-06-01">20-5455398</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-06-01_to_2021-06-01">6000 Shoreline Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2021-06-01_to_2021-06-01">Suite&#160;300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-06-01_to_2021-06-01">South San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2021-06-01_to_2021-06-01">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-06-01_to_2021-06-01">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2021-06-01_to_2021-06-01">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-06-01_to_2021-06-01">243-6300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-06-01_to_2021-06-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-06-01_to_2021-06-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-06-01_to_2021-06-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-06-01_to_2021-06-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-06-01_to_2021-06-01">Common Stock, par value, $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-06-01_to_2021-06-01">VCYT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-06-01_to_2021-06-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-06-01_to_2021-06-01">false</dei:EntityEmergingGrowthCompany>
    <dei:AmendmentDescription contextRef="duration_2021-06-01_to_2021-06-01">This Amendment No.&#160;1 on Form 8-K/A is an amendment to the Current Report on Form 8-K (the &#x201c;Form 8-K&#x201d;) of Veracyte, Inc., a Delaware corporation (&#x201c;Veracyte&#x201d;), filed with the Securities and Exchange Commission on June&#160;1, 2021, for the sole purpose of removing the check mark in the box relating to written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425), which was inadvertently checked in the Form 8-K. All other information in the Form 8-K is unchanged.</dei:AmendmentDescription>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140233001388120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  01,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VERACYTE, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-5455398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6000 Shoreline Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite&#160;300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">243-6300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value, $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VCYT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">This Amendment No.&#160;1 on Form 8-K/A is an amendment to the Current Report on Form 8-K (the &#8220;Form 8-K&#8221;) of Veracyte, Inc., a Delaware corporation (&#8220;Veracyte&#8221;), filed with the Securities and Exchange Commission on June&#160;1, 2021, for the sole purpose of removing the check mark in the box relating to written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425), which was inadvertently checked in the Form 8-K. All other information in the Form 8-K is unchanged.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001384101<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M*J5T_C_5Y9;7:J4=<I$Q17]Z[0Z==SW'L;$\T'/WNUA.= N/QI)OZ]7<#K?
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M='@//GL?)=-[*CG_5U/\!%!+ P04    " !EA,A2EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( &6$R%(<.&7J/P$
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M?P%02P$"% ,4    " !EA,A2!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( &6$R%(].(_:[@   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( &6$R%*97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ 983(4O60X@1W!0  B1,  !@
M         ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( &6$R%*?H!OPL0(  .(,   -              "  ;H-  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ 983(4I>*NQS     $P(   L
M ( !EA   %]R96QS+RYR96QS4$L! A0#%     @ 983(4APX9>H_ 0  / (
M  \              ( !?Q$  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M &6$R%(D'INBK0   /@!   :              "  >L2  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( &6$R%)ED'F2&0$  ,\#   3
M              "  = 3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(  !H5      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d188784d8ka.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K/A" original="d188784d8ka.htm">d188784d8ka.htm</File>
    <File>d188784dex991.htm</File>
    <File>vcyt-20210601.xsd</File>
    <File>vcyt-20210601_lab.xml</File>
    <File>vcyt-20210601_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d188784d8ka.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d188784d8ka.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vcyt-20210601_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vcyt-20210601_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "vcyt-20210601.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "vcyt",
   "nsuri": "http://www.veracyte.com/20210601",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d188784d8ka.htm",
      "contextRef": "duration_2021-06-01_to_2021-06-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d188784d8ka.htm",
      "contextRef": "duration_2021-06-01_to_2021-06-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description",
        "terseLabel": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.veracyte.com//20210601/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-21-185455-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-185455-xbrl.zip
M4$L#!!0    ( &6$R%*-(@RI/QD  #"&   /    9#$X.#<X-&0X:V$N:'1M
M[5WM<]LVTO_^S#S_ T9]TK-G].Z7V++C&Y_BM+XF3LYV>^WSI0.1D,2&(EB
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M8SJ9AN)-Q0]T'/(IZJ:HG+'38-+!-X2R_PY\7T3FW]#DRB@F"_PWE>_IT:_
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ME'QM5NASS'W??;9CV;EZ,@QYK$7'_>-^&<D)%"(YPXU6L_G*\J[3M&1VFB[
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MF/2@L)O*\TC<+1_FCRD21\Q .UUBH+@%WZXS%UJ<F$B;9#J(AH(TW*H4X,<
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M$Y\T CW'JU91A'+C&60TCXI*1&AXF_O.&<LTH?"A:K93<1\6W&#5>K!<"HK
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MMOC+#]O/MO?%P8=*9WMBF$8'FQ\.!^*G=]*.Y><]\?'XU^N?PZ[2U)38]5C
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M62*7[0>4PUE9L7(>_GFWX[X8*\O]'7XTUX@A];',(<L^=K'N<B^+.G4HF3'
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MBWTHAV2;F\1HB=M'*<N-SM$X09-EKLQ)@*'!?B?P;XFP:OI'R7L1-7WELG+
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M,:S=C34;F@"\P(O-  Q, S XN@ ,Z@9@8", @^\7@,F&6PL DHW: :CT8C,
M0], #(\N ,.Z 1C:",#P.P9 \F#O>P"2D?H1J':#'H*Q/+P3$[YA+XI OOP8
M J"QH\/_:1D:_,\E+:&OVJB['ZH1+O38!JJ0K^<"'?;XWM&=N!?\D3*OX7W0
M,HUCP+[,F([]9VO1 J#5M92";S<!LVZX4;!BI2H/#?R@A^*>AY$;_$U7S1\-
MZ!6.(1!Z4[HX%%:BA4&C:BD*22>0K3!O]=NS416#VEY0/O:E; KB-L&^6-/6
MA[YT@_/]:T8?^=K30<(W_LZOE'%HQ9^S\'&OFL-BX*@^DQG<+SAK^)!IOZXE
M+$L-</UU$SSU6DB(QN(0JV/=9K<S;Q[5)D-CX/JGH%%$V)@OEVN6WL0/ZS);
M4MP2N-56>,4B$X0K!)$X3CM L84QRQ8'SP/=='H,J!]X0#T:43:_E?MQ0=V@
M+M&ZRI9PKC#!RU:8@%RFAD3QDSQD^L8(VQHYSV^CN3'@O1=$985(..(/'*M?
MEQ!WLUG]K4250DLPUS#%#ZTT@?N0*A+DLHWCY?I T@CB3L:XVS:1Q_Z%3BP$
MX#H,UT28QT"C<QQA*#>HC\3>>L1@E&C;BD?2SFI*+#FJS$HC6R@;'N*MY3YK
MUQ],)S0*:M\'V:]K:[-39H#KKQMM=+1:2(C'BL!GT!^\F;Z%K)?Y5L?*T'F*
M&T^. >Y$N.IWCQ]VRRFOO4E_5M02LOK1N>:B":P:(2Q2$V5(I(T!M3!H@<Z:
MTV*^FUYNO87T3)K\)I&^MN5W5:T17KX&X]UU7P_K!\FT 60=<'Z3R-[<A9\F
M&PZ/]Y3P<DG$7";H-\$WT4+ND%8NVS5[3%@BT>ISPFI;_.!2\R>%%;)(Q*>/
MU[)&D'2"M!72DT*+-C2/"AM[P0C"N=R<^VJ#?D%"3]"5NA-9-P'ZVI;0KS3"
MR]>8P%ZNAT3YMP:0ZV ,M[VQ\U0WG!T5YJO G3>F."EJ&]_"Z,^Y51=1@'T2
M0B=52>,ABC>HGLWJ:?&V&F/93+C!-?/)]G?2<).Q5]SJ]J+,"J]89+ZET KB
M;B;2%A#W -D$:1MA973-!N+P_/D3-_)(_3=?Z2F:_&=7\LS_4$L#!!0    (
M &6$R%)##;]TUP0  #8P   5    =F-Y="TR,#(Q,#8P,5]P<F4N>&ULW9KO
M;^(V&,??GW3_@Y=[LTD+(4FO=T6E)T3;":T_$.6V:6].)GD :XD=V:; ?S\[
MX%X"H4?:W11?7P!U_'W\]?-QC'%\_FF5)N@1N"",=AV_U780T(C%A,ZZSD*X
M6$2$.$A(3&.<, I=9PW"^73Q]LWY3ZZ++J\'=\A%<RDST?&\Y7+9BJ>$"I8L
MI HI6A%+/>2ZIGY__!G]L6FN@TX_M,+B-0Y8BU",):BKWD<O: <^"COA62<X
M0<-;=(6%!$[1F*105+)LS<EL+M'/T2\H%UTR2B%)8(VN"<4T(CA!#\;5KVA
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MJW+N[27E1A7HL_";*_I%G^Q6)?\"4$L! A0#%     @ 983(4HTB#*D_&0
M,(8   \              ( !     &0Q.#@W.#1D.&MA+FAT;5!+ 0(4 Q0
M   ( &6$R%+SD'MVA1<  -Y2   1              "  6P9  !D,3@X-S@T
M9&5X.3DQ+FAT;5!+ 0(4 Q0    ( &6$R%**ZIWA'0,  ,D*   1
M      "  2 Q  !V8WET+3(P,C$P-C Q+GAS9%!+ 0(4 Q0    ( &6$R%(%
M><7!P@8  !%-   5              "  6PT  !V8WET+3(P,C$P-C Q7VQA
M8BYX;6Q02P$"% ,4    " !EA,A20PV_=-<$   V,   %0
M@ %A.P  =F-Y="TR,#(Q,#8P,5]P<F4N>&UL4$L%!@     %  4 00$  &M
$      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
